Company performance
Add to research
Current Price
as of Feb 14, 2025$24.85
P/E Ratio
N/A
Market Cap
$1.81B
Description
Add to research
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Metrics
Add to research
Overview
- HQNew York, NY
- SectorTechnology Services
- IndustryPackaged Software
- TickerSDGR
- Price$24.85+1.72%
Trading Information
- Market cap$1.81B
- Float85.21%
- Average Daily Volume (1m)1,201,881
- Average Daily Volume (3m)812,110
- EPS-$2.45
Company
- Revenue$193.35M
- Rev growth (1yr)-17.10%
- Net income-$38.14M
- Gross margin50.24%
- EBITDA margin-189.47%
- EBITDA-$66.86M
- EV$1.07B
- EV/Revenue5.55
- P/EN/A
- P/S9.36
- P/B4.03
- Debt/Equity26.73
Documents
Add to research
SEC Filings
Earnings Calls